Pfizer CEO Albert Bourla joins CNBC's 'Special Report' as President-elect Donald Trump is inaugurated as the 47th U.S.

Albert Bourla and other healthcare CEOs talked about the efficacy of vaccines and how public health could take a big turn for ...

Pfizer Chairman and CEO Albert Bourla did not mince his words at the 43rd annual J.P. Morgan Healthcare Conference in San Francisco on Monday regarding the controversial positions that Robert F.

It’s not just the tech billionaires descending on Washington. Plenty of chief executives from other industries are also ...

Of the 24 analysts covering Pfizer, 11 have a “Strong Buy” rating while 12 rate it as a “Hold” or some equivalent. One ...

The announcement came days after Netanyahu said in a video address that Israel would be able to sign a deal with Pfizer in part because the company’s CEO, Albert Bourla, told Netanyahu he is ...

Riley Wealth Management chief market strategist Art Hogan discusses whether the Fed's interest rate move changed his investment focus on 'The Claman Countdown.' Euro Pacific Capital chief economist ...

Two former Pfizer executives drawn into a campaign ... saying they are "fully supportive of Pfizer chairman and CEO Albert Bourla, senior management and the board, and we are confident that ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

Pfizer has promoted Albert Bourla, seen as a likely successor to incumbent CEO Ian Read, to the newly-created role of chief operating officer. The move could help Read focus on long-term strategy ...

The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over ...

FDA Commissioner Robert Califf is closing the book on his second stint leading the agency that regulates products accounting ...